Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurorepair effects of antidepressant treatment during remission in recurrent depression
2006-004457-20Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tianeptine, venlafaxine and mirtazapine in major depressive disorder (MDD) (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Hippocampal volume by MRI and Gray matter density on MRI. Started Mar 2008; status: active.
02
Drugs
tianeptinevenlafaxinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-004457-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004457-20.